• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Hexestrol

Hexestrol

Product ID H1894
Cas No. 84-16-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $71.50 In stock
5 g $245.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Hexestrol is a synthetic catechol that exhibits carcinogenic and estrogenic activities. Hexestrol inhibits tubulin assembly and induces mitotic arrest and aneuploidy in vitro. Hexestrol also forms DNA adducts, potentially initiating carcinogenesis.

Product Info

Cas No.

84-16-2

Purity

≥98%

Formula

C18H22O2

Formula Wt.

270.37

Chemical Name

4,4'-(1,2-Diethylethyl-1,2-ethanediyl)bisphenol

IUPAC Name

4-[4-(4-hydroxyphenyl)hexan-3-yl]phenol

Synonym

Dihydrodiethylstilbestrol, Synthovo, Cycloestrol, Hormoestrol, Syntrogene

Melting Point

185-188°C

Solubility

Soluble in ether, acetone, alcohol, and methanol. Slightly soluble in benzene and chloroform.

Appearance

White or Almost White Crystalline Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

H1894 MSDS PDF

Info Sheet

H1894 Info Sheet PDF

References

Cavalieri EL, Rogan EG. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci. 2004 Dec;1028:247-57. PMID: 15650250.

Chaudoreille MM, Peyrot V, Braguer D, et al. Qualitative study of the interaction mechanism of estrogenic drugs with tubulin. Biochem Pharmacol. 1991 Mar 1;41(5):685-93. PMID: 1847811.

Wheeler WJ, Cherry LM, Downs T, et al. Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro. Mutat Res. 1986 Jul;171(1):31-41. PMID: 3724781.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D3200

    Diacetoxyscirpenol

    Type A trichothecene mycotoxin produced by Fusa...

    ≥98%
  • E6398

    EPZ-5676

    DOT1L HMT inhibitor.

    ≥98%
  • O4101

    Okadaic Acid

    Shellfish toxin produced by dinoflagellates and...

    ≥98%
  • T2792

    TGX-221

    p110β PI3K inhibitor.

  • Z4900

    ZM-447439 Trihydrate

    AurKA/B inhibitor.

    ≥99%
  • A0970

    Adrenocorticotropic Hormone (18-39), human

    Endogenous peptide hormone fragment, involved i...

    ≥95%
  • N5655

    Nonoxynol-9

    Nonoxynol surfactant.

    90-110%
  • T3350

    Timolol Maleate

    β-adrenergic antagonist.

    ≥98%
  • A0819

    Acetylsalicylic Acid

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • S0049

    Salmon Calcitonin Acetate

    Peptide, involved in feeding behavior and insul...

    ≥95%
  • A3080

    AHU-377 Tris Salt

    LBQ657 prodrug; neprilysin inhibitor.

    ≥99%
  • C0156

    9-Nitro-20S-camptothecin

    Camptothecin derivative; topoisomerase I inhibi...

    ≥98%
  • C4646

    Clofarabine

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%
  • P4403

    Plasminogen Activator Inhibitor 1

    Endogenous peptide, produced by activation of P...

    ≥95%
  • N3323

    Nifuratel

    Nitrofuran derivative.

    ≥99%
  • A9814

    AZD-4547

    FGFR inhibitor.

    ≥98%
  • Z0222

    Zafirlukast

    VEGF-C/Nrp2 inhibitor. Leukotriene receptor ant...

    ≥98%
  • T6902

    Tranilast

    Mast cell stabilizer; TRPV2 antagonist, PDGFR i...

    ≥98%
  • R3584

    Rivaroxaban

    Oxazolidone derivative; Factor Xa inhibitor.

    ≥98%
  • R0161

    Rapamycin

    Macrolide originally produced by Streptomyces; ...

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only